- Home
- PCB vs ATYR Comparison
PCB vs ATYR Comparison
Compare PCB & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCB
- ATYR
- Stock Information
- Founded
- PCB 2003
- ATYR 2005
- Country
- PCB United States
- ATYR United States
- Employees
- PCB 259
- ATYR N/A
- Industry
- PCB Major Banks
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PCB Finance
- ATYR Health Care
- Exchange
- PCB Nasdaq
- ATYR Nasdaq
- Market Cap
- PCB 287.2M
- ATYR 290.6M
- IPO Year
- PCB N/A
- ATYR 2015
- Fundamental
- Price
- PCB $20.31
- ATYR $3.31
- Analyst Decision
- PCB Hold
- ATYR Strong Buy
- Analyst Count
- PCB 2
- ATYR 6
- Target Price
- PCB $22.00
- ATYR $18.60
- AVG Volume (30 Days)
- PCB 40.4K
- ATYR 1.1M
- Earning Date
- PCB 04-24-2025
- ATYR 05-07-2025
- Dividend Yield
- PCB 4.02%
- ATYR N/A
- EPS Growth
- PCB 11.00
- ATYR N/A
- EPS
- PCB 1.94
- ATYR N/A
- Revenue
- PCB $98,720,000.00
- ATYR N/A
- Revenue This Year
- PCB $16.13
- ATYR $551.06
- Revenue Next Year
- PCB $10.77
- ATYR $2,144.84
- P/E Ratio
- PCB $10.27
- ATYR N/A
- Revenue Growth
- PCB 5.07
- ATYR N/A
- 52 Week Low
- PCB $14.50
- ATYR $1.42
- 52 Week High
- PCB $22.20
- ATYR $4.66
- Technical
- Relative Strength Index (RSI)
- PCB 66.42
- ATYR 53.63
- Support Level
- PCB $19.66
- ATYR $3.06
- Resistance Level
- PCB $20.34
- ATYR $3.45
- Average True Range (ATR)
- PCB 0.54
- ATYR 0.23
- MACD
- PCB 0.12
- ATYR 0.01
- Stochastic Oscillator
- PCB 99.46
- ATYR 60.66
About PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.